Israel’s BrainStorm says stem cell drug benefits most patients in ALS trial

Your Health Matters

TEL AVIV (Reuters) – Israel’s BrainStorm Cell Therapeutics said final results from a clinical trial of its adult stem cell treatment in amyotrophic lateral sclerosis (ALS) were positive, with most patients showing a slowing in the disease’s progression. According to the ALS Association, 5,600 people in the United States are diagnosed each year with the neurodegenerative disease, which has severely disabled British physicist Stephen Hawking. …
Go to Source

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave